EGFR High Copy Number Together with High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis from SWOG S0819, a phase III trial of chemotherapy with or without Cetuximab in advanced NSCLC

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.10.002 ◽

2021 ◽

Author(s):

F.R. Hirsch ◽

M.W. Redman ◽

J. Moon ◽

F. Agustoni ◽

R.S. Herbst ◽

...

Keyword(s):

Lung Cancer ◽

Protein Expression ◽

Squamous Cell ◽

Cell Lung Cancer ◽

Copy Number ◽

Advanced Nsclc ◽

Phase Iii ◽

High Copy Number ◽

Phase Iii Trial ◽

Improved Outcome

Download Full-text

Efficacy and Safety of Carboplatin With Nab-Paclitaxel Versus Docetaxel in Elderly Patients with Squamous-Cell Lung Cancer (CAPITAL): A Randomized, Multicenter, Open-Label, Phase III Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3847741 ◽

2021 ◽

Author(s):

Yoshihito Kogure ◽

Shunichiro Iwasawa ◽

Hideo Saka ◽

Yoichiro Hamamoto ◽

Akiko Kada ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Squamous Cell ◽

Cell Lung Cancer ◽

Phase Iii ◽

Squamous Cell Lung Cancer ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Trial ◽

Open Label Phase

Download Full-text

Randomized phase III trial of erlotinib vs. docetaxel in patients with advanced squamous cell non-small cell lung cancer (SqNSCLC) failing first line platinum based doublet chemotherapy stratified by VeriStrat Good vs VeriStrat Poor: The European Thoracic Oncology Platform (ETOP) EMPHASIS trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8049 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8049-8049

Author(s):

Solange Peters ◽

Egbert F. Smit ◽

Urania Dafni ◽

Santiago Ponce Aix ◽

Bartomeu Massuti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Squamous Cell ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

First Line ◽

Phase Iii Trial ◽

Doublet Chemotherapy

Download Full-text

Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.12.017 ◽

2017 ◽

Vol 12 (4) ◽

pp. 752-762 ◽

Cited By ~ 10

Author(s):

Solange Peters ◽

Rolf A. Stahel ◽

Urania Dafni ◽

Santiago Ponce Aix ◽

Bartomeu Massutí ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Squamous Cell ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

First Line ◽

Phase Iii Trial ◽

Doublet Chemotherapy

Download Full-text

Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non[ndash ]small cell lung cancer

Seminars in Oncology ◽

10.1053/sonc.2001.24366 ◽

2001 ◽

Vol 28 (2D) ◽

pp. 7-10

Author(s):

Pasquale Comella

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)

BioDrugs ◽

10.1007/s40259-021-00489-4 ◽

2021 ◽

Author(s):

Konstantinos Syrigos ◽

Istvan Abert ◽

Zoran Andric ◽

Igor N Bondarenko ◽

Mikhail Dvorkin ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

Annals of Oncology ◽

10.1093/annonc/mdu098 ◽

2014 ◽

Vol 25 (5) ◽

pp. 1044-1052 ◽

Cited By ~ 96

Author(s):

F. Barlesi ◽

A. Scherpereel ◽

V. Gorbunova ◽

R. Gervais ◽

A. Vikström ◽

...

Keyword(s):

Lung Cancer ◽

Survival Analysis ◽

Cell Lung Cancer ◽

Nonsmall Cell Lung Cancer ◽

Phase Iii ◽

First Line ◽

Phase Iii Trial

Download Full-text

Randomized Phase III Trial of Dose-Dense Chemotherapy Supported by Whole-Blood Hematopoietic Progenitors in Better-Prognosis Small-Cell Lung Cancer

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/dji114 ◽

2005 ◽

Vol 97 (9) ◽

pp. 666-674 ◽

Cited By ~ 55

Author(s):

Paul Lorigan ◽

Penella J. Woll ◽

M. E. R. O'Brien ◽

Linda F. Ashcroft ◽

Mark R. Sampson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Whole Blood ◽

Small Cell ◽

Phase Iii ◽

Hematopoietic Progenitors ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Dose Dense

Download Full-text

Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2004.01.055 ◽

2004 ◽

Vol 59 (4) ◽

pp. 943-951 ◽

Cited By ~ 121

Author(s):

Steven E. Schild ◽

James A. Bonner ◽

Thomas G. Shanahan ◽

Burke J. Brooks ◽

Randolph S. Marks ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Long Term Results ◽

Small Cell Lung ◽

Once Daily ◽

Phase Iii Trial

Download Full-text

Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial Data

Journal of Oncology Practice ◽

10.1200/jop.1.2.37 ◽

2005 ◽

Vol 1 (2) ◽

pp. 37-42 ◽

Cited By ~ 2

Author(s):

M. R. Green ◽

M. Andrews ◽

R. Leff ◽

J. Willey ◽

C. Allegra ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Trial Data ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Treatment Plans

Download Full-text

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2017.05.037 ◽

2017 ◽

Vol 83 ◽

pp. 302-312 ◽

Cited By ~ 8

Author(s):

David Ferry ◽

Lucinda Billingham ◽

Hugh Jarrett ◽

David Dunlop ◽

Penella J. Woll ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text